NCPDP Foundation Awards Research Grant to College to Evaluate the NCPDP/HL7 Specialty Medication Enrollment Standard
The NCPDP Foundation Board of Trustees announced it has awarded a $102,300 research grant to the University of Minnesota College of Pharmacy to evaluate the quality of data obtained from EHRs using the NCPDP/HL7 Specialty Medication Enrollment Standard.
Dr. Carrie Haskell-Luevano loves being a researcher. As a professor and Philip S. Portoghese Endowed Chair in Chemical Neuroscience, she finds joy in teaching students and making discoveries alongside her laboratory staff. Read about the value she finds in her partnership with UMN Technology Commercialization.
The results of Phase 2 clinical trials for glaucoma drug QLS-101 have demonstrated a favorable safety and tolerability profile, according to a news release by Qlaris Bio, which licensed the drug in 2019. A positive efficacy signal was also reported.
The Midwest Antiviral Drug Discovery (AViDD) Center is part of a network of nine national centers established in response to the public health emergency.
Goal of new center is to transform the way pharmaceutical drugs are formulated and manufactured.
The College of Pharmacy has worked in collaboration with the Center for Allied Health Programs (CAHP), the Academic Health Sciences, and the Provost’s office to move the CAHP into the College of Pharmacy.